Free Trial

Viridian Therapeutics (VRDN) SEC Filings & 10K Form

Viridian Therapeutics logo
$19.23 +1.21 (+6.71%)
Closing price 04:00 PM Eastern
Extended Trading
$19.09 -0.14 (-0.73%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Viridian Therapeutics SEC Filings

DateFilerForm TypeView
08/06/2025
6:03 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025
6:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2025
6:10 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
3:43 PM
Moses Jennifer K. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:43 PM
Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:43 PM
Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:45 PM
Morris Arlene (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:46 PM
Kiselak Tomas (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:15 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:00 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:16 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
10:44 AM
Kynam Capital Management, LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G
05/06/2025
6:55 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
6:28 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
6:54 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/25/2025
6:57 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:59 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/11/2025
4:15 PM
COMMODORE CAPITAL LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G
04/09/2025
3:19 PM
Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2025
3:26 PM
Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:12 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:27 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:36 PM
Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:17 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:19 PM
CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:12 PM
Harmon Seth (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:13 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:14 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:17 PM
Tousignant Jennifer (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:09 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
03/03/2025
3:35 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:33 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:05 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:22 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:52 PM
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:53 PM
Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:50 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:33 PM
Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:15 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)

So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel

🎯 Click here to watch the video and get the free ticker XGPT just flagged.
10/18/2024
11:33 AM
STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
09/30/2024
6:12 PM
Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:10 PM
Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
09/17/2024
8:00 PM
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:07 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/12/2024
4:25 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:28 PM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/10/2024
6:11 AM
Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRDN) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners